NCT01894152View on ClinicalTrials.gov

XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study

CompletedOBSERVATIONAL
Enrollment

2,002

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 9, 2019

Study Completion Date

October 9, 2019

Conditions
AngioplastyCardiovascular DiseaseCoronary Artery DiseaseCoronary Heart DiseaseCoronary RestenosisMyocardial InfarctionStent ThrombosisVascular Disease
Interventions
DEVICE

XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS)

Subjects receiving XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS)

Trial Locations (1)

95054

Abbott Vascular, Santa Clara

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT01894152 - XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study | Biotech Hunter | Biotech Hunter